Recode invests in companies that see deeper and reach higher

Transformational approach to heart disease detection and management. Convenient, cost-effective echocardiograms whenever and wherever patients need them — including the home.

An AI operating layer for pharma. It turns fragmented systems and manual workflows into context-aware, auditable AI agents for regulatory documentation, drug-design support, and document processing across the value chain.

Lab Genius combines human and machine intelligence to accelerate the discovery of advanced medicines.

Nanograb using computational biology and AI to target genetic drugs to specific tissues inside the body.

An AI health agent for navigating access to care. It uses large language models and a patented data engine to match members with the right in-network providers, then automates scheduling, outreach, and follow-up across voice and text.

A precision oncology company. It uses AI-based biomarker tests on tissue and blood to personalise cancer diagnosis and treatment, including validated assays for metastatic disease.

Patients with rare conditions can take years to receive a correct diagnosed. Probably Genetic shrinks this odyssey to months by using its proprietary platform.

Proprio is a tech company improving how surgeries are planned, carried out by blending the knowledge of doctors with advanced, interactive technologies such as AR/VR.

Sensible uses a novel approach to design and generate mRNA for therapeutic applications.

AI infrastructure for clinical trials. It builds full study traceability to automate SDTM and ADaM validation and to generate submission documentation, helping teams reach regulatory submission readiness in hours.

Waypoint Bio uses spatial biology and novel AI/ML to rationally design better cell therapies for cancers.